The Claim
In a dihydrotestosterone (DHT)-induced polycystic ovary syndrome (PCOS) mouse model, daily oral administration of 1 × 10⁹ colony-forming units (CFU) of Bifidobacterium longum BL21 for 8 weeks is associated with increased gut microbiota diversity, enrichment of beneficial bacterial genera (Bifidobacterium, Lactobacillus, Butyricicoccus, and Blautia), and reduction in pro-inflammatory genera (Helicobacter and Alistipes), suggesting a modulatory effect on gut microbial composition.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Giving a specific probiotic to mice with a condition like PCOS seems to improve their gut bacteria, boosting good kinds and reducing harmful ones after 8 weeks.
See the scientific wording
In DHT-induced PCOS model mice, 8 weeks of daily oral supplementation with 1 × 10⁹ CFU of Bifidobacterium longum BL21 is associated with increased gut microbiota diversity and enrichment of beneficial genera including Bifidobacterium, Lactobacillus, Butyricicoccus, and Blautia, while reducing pro-inflammatory genera such as Helicobacter and Alistipes, indicating a modulatory effect on gut microbial composition.
What the research says
1 studyThe study gave a specific probiotic to mice with PCOS for 8 weeks and found it improved gut health and reduced inflammation, which matches the main points of the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.